Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women

Mehmet A. Osmanağaoğlu, T. Atasaral, Davut Baltacı, Hasan Bozkaya
In: Climacteric · 2006 · vol. 9(6) , pp. 464–472 · doi:10.1080/13697130600997775 · PMID:17085380 · W2041056368
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

Tibolone treatment improved sexual performance, including desire, arousal, and satisfaction, more than estradiol/dienogest or no therapy in postmenopausal women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To compare the effect of different formulations of continuous combined hormone therapy on sexual performance in naturally postmenopausal women. MATERIAL AND METHODS: A total of 158 postmenopausal women were enrolled and prospectively randomized to the single-blind study. Fifty-four women received tibolone 2.5 mg, 53 received 2 mg estradiol and 2 mg dienogest (E2/dienogest), and 51 did not receive any menopausal therapy. The patients were monitored after 6 months. Attitudes of sexuality were evaluated by using the Rosen's female sexual function index. RESULTS: Compared with E2/dienogest and the control group, tibolone treatment was associated with more improvement of sexual performance, including sexual desire, sexual arousal and satisfaction. Both of the hormone therapies decreased frequencies of vaginal dryness and painful intercourse. CONCLUSIONS: Tibolone has more positive effects on the sexual dysfunction of postmenopausal women and may be an alternative to the E2/dienogest preparation in postmenopausal women with sexual dysfunction.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (20)

Source provenance

openalex
last seen: 2026-05-11T06:42:59.773506+00:00
License: CC0 · commercial use OK